A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Everolimus (Primary) ; Letrozole (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 20 Feb 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 18 Feb 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Apr 2017, according to ClinicalTrials.gov record.
- 18 Feb 2014 Planned End Date changed from 1 Apr 2015 to 1 Apr 2016, as per ClinicalTrials.gov record.